CAPTRUST Financial Advisors
AVXL icon

CAPTRUST Financial Advisors’s Anavex Life Sciences AVXL Stock Holding History

CAPTRUST Financial Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.9K Buy
+10,784
New +$31.9K ﹤0.01% 3183
2022
Q3 		– Sell
-1,000
Closed -$10K – 2232
2022
Q2 		$10K Hold
1,000
– – ﹤0.01% 3734
2022
Q1 		$12K Sell
1,000
-23
-2% -$283 ﹤0.01% 3691
2021
Q4 		$18K Buy
1,023
+23
+2% +$437 ﹤0.01% 3345
2021
Q3 		$18K Sell
1,000
-427
-30% -$8.5K ﹤0.01% 3218
2021
Q2 		$33K Sell
1,427
-2,017
-59% -$29.9K ﹤0.01% 2768
2021
Q1 		$51K Buy
3,444
+1,944
+130% +$21.2K ﹤0.01% 2412
2020
Q4 		$8K Hold
1,500
– – ﹤0.01% 2650
2020
Q3 		$6K Hold
1,500
– – ﹤0.01% 2458
2020
Q2 		$8K Buy
+1,500
New +$5.67K ﹤0.01% 2246

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CAPTRUST Financial Advisors's AVXL Position: Q2 2026 in Review

CAPTRUST Financial Advisors opened a new position in Anavex Life Sciences (AVXL) in Q2 2026: 10,784 shares worth $27.9K. The stake represents ﹤0.01% of the portfolio and ranks #3183 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in AVXL as recently as Q2 2022.

CAPTRUST Financial Advisors first reported a position in AVXL in Q2 2020 and has held it in 10 quarters since. The position peaked at $51K in Q1 2021. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • CAPTRUST Financial Advisors held 10,784 shares of Anavex Life Sciences worth $27.9K as of Q2 2026.
  • Anavex Life Sciences was a new CAPTRUST Financial Advisors position in Q2 2026.
  • Anavex Life Sciences made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #3183 holding.
  • CAPTRUST Financial Advisors first reported a position in Anavex Life Sciences in Q2 2020 and has held it in 10 quarters since.
  • CAPTRUST Financial Advisors's Anavex Life Sciences position peaked at $51K in Q1 2021.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.